1. REMUS PHARMACEUTICALS L
stock logo

REMUS PHARMACEUTICALS L Share Price

REMUS

₹2,540.00-₹2.60 (-0.1%) TodayLast updated on 05 Nov, 2024 | 15:28 IST

REMUS PHARMACEUTICALS L Share Price Chart

Please wait...
  • Company overview
  • Fundamentals
  • Events
  • More

Company overview

REMUS PHARMACEUTICALS L Financials

arrow
Market cap
Market Cap Switch₹1,498 Crs
Open
₹2,542.60
Close
₹2,542.60
Circuit range
₹3,051.10 - ₹2,034.10
Day range
₹2,525.00 - ₹2,550.00
Year range
₹1,785.10 - ₹8,747.00
Volume
1,250
Avg. traded
₹2,536.21
Revenue (12m)
₹212 Crs
REMUS PHARMACEUTICALS LRemus Pharmaceuticals Limited is engaged in marketing and distribution of finished formulations of pharmaceutical drugs. The Company also deals in active pharmaceutical ingredient (API). It also provides technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. It deals in drug forms like capsules, cream, eye drops, gel, infusion, inhalation, inhaler, injection, nail lacquer, nasal solution, nasal spray, nebulizer, ointment, ophthalmic, oral gel, oral solution, oral suspension, sachet, suspension, tablet. The therapeutic areas it works include oncology, cardiovascular, anti-diabetic, immune suppressants, anti-biotic, antibacterial, dermatology, central nervous system, and others. Its oncology products include Sorafenib Tablets, Enzalutamide Capsules, Lenalidomide Capsule, and others. Its cardiovascular products include Rivaroxaban Tablets, Ticagrelor Tablets, and others.

REMUS PHARMACEUTICALS L Key indicators

arrow
52 week high
₹8,747.00
52 week low
₹1,785.10
P/E ratio
68.1
P/B ratio
16.6
ROE
33.24%
ROCE
41.31%
Dividend yield
0.23%
Debt/Equity ratio
0.02
EPS
114.19

Learn more

Investment checklist: (3/6)
arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

REMUS PHARMACEUTICALS L Fundamentals

REMUS PHARMACEUTICALS L Financial Ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

37.38%

Net profit margin

26.49%

ROE

33.24%

ROA

25.53%

ROCE

41.31%

Learn more

REMUS PHARMACEUTICALS L Shareholder returns

arrow
1 day
-3.41%
1 week
+4.16%
1 month
-1.29%
3 months
+15.97%
1 year
-55.45%
3 years
+41.51%
5 years
+41.51%

REMUS PHARMACEUTICALS L Share Price history

arrow
DayOpenCloseChange %
Mon, Nov 4 2024
₹2,625.00
₹2,542.60
-3.41%
Fri, Nov 1 2024
₹2,648.00
₹2,632.30
+0.60%
Thu, Oct 31 2024
₹2,620.00
₹2,616.70
+0.69%
Wed, Oct 30 2024
₹2,580.00
₹2,598.75
+1.06%
Tue, Oct 29 2024
₹2,450.00
₹2,571.45
+5.34%
Mon, Oct 28 2024
₹2,406.50
₹2,441.00
+1.51%
Fri, Oct 25 2024
₹2,544.00
₹2,404.75
-1.81%
Thu, Oct 24 2024
₹2,462.00
₹2,449.00
-1.32%

REMUS PHARMACEUTICALS L Shareholding Pattern

arrow

Promoters (70.84%)

Mutual Funds (0%)

Retail and other (25.22%)

Foreign institutions-FII (3.16%)

Other domestic institutions (0.77%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Bonus • 3:1

    Ex date 06 Jun 2024

    expand tab
  • Dividend • ₹4/share

    Ex date 02 May 2024

    expand tab
  • Dividend • ₹2/share

    Ex date 27 Oct 2023

    expand tab
  • Dividend • ₹2/share

    Ex date 15 Sep 2023

    expand tab

Learn more

FAQs on REMUS PHARMACEUTICALS L